Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 27;9(2):e89321.
doi: 10.1371/journal.pone.0089321. eCollection 2014.

Gene expression alterations in the cerebellum and granule neurons of Cstb(-/-) mouse are associated with early synaptic changes and inflammation

Affiliations

Gene expression alterations in the cerebellum and granule neurons of Cstb(-/-) mouse are associated with early synaptic changes and inflammation

Tarja Joensuu et al. PLoS One. .

Abstract

Progressive myoclonus epilepsy of Unverricht-Lundborg type (EPM1) is an autosomal recessively inherited neurodegenerative disease, manifesting with myoclonus, seizures and ataxia, caused by mutations in the cystatin B (CSTB) gene. With the aim of understanding the molecular basis of pathogenetic events in EPM1 we characterized gene expression changes in the cerebella of pre-symptomatic postnatal day 7 (P7) and symptomatic P30 cystatin B -deficient (Cstb(-/-) ) mice, a model for the disease, and in cultured Cstb(-/-) cerebellar granule cells using a pathway-based approach. Differentially expressed genes in P7 cerebella were connected to synaptic function and plasticity, and in cultured cerebellar granule cells, to cell cycle, cytoskeleton, and intracellular transport. In particular, the gene expression data pinpointed alterations in GABAergic pathway. Electrophysiological recordings from Cstb(-/-) cerebellar Purkinje cells revealed a shift of the balance towards decreased inhibition, yet the amount of inhibitory interneurons was not declined in young animals. Instead, we found diminished number of GABAergic terminals and reduced ligand binding to GABAA receptors in Cstb(-/-) cerebellum. These results suggest that alterations in GABAergic signaling could result in reduced inhibition in Cstb(-/-) cerebellum leading to the hyperexcitable phenotype of Cstb(-/-) mice. At P30, the microarray data revealed a marked upregulation of immune and defense response genes, compatible with the previously reported early glial activation that precedes neuronal degeneration. This further implies the role of early-onset neuroinflammation in the pathogenesis of EPM1.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Differential expression of Gabra6 and Gabrd.
qPCR shows increased expression of Gabra6 and Gabrd in P7 Cstb−/− cerebellum compared to the control mice. The data are expressed as a fold change relative to controls ± SE. *, p<0.05.
Figure 2
Figure 2. Spontaneous postsynaptic currents in Purkinje cells.
(A) Representative traces of spontaneous EPSCs and IPSCs in control and Cstb−/− Purkinje cells. EPSCs are seen as inward currents (downward deflections) and IPSCs are seen as outward currents (upward deflections). Insets show single IPSCs and EPSCs taken from the time points indicated by asterisks. An arrow indicates a synchronous burst of IPSCs seen in control but not in Cstb−/− Purkinje cells. (B) The occurrence of IPSCs and synchronous burst of IPSCs on control and Cstb−/− Purkinje cells. Individual cells measured are shown as spheres. (C) The frequency of EPSCs was significantly higher in Cstb−/− cells compared to controls (p = 0.034). The data are expressed as mean frequency (Hz) ± SE. *, p<0.05; **, p<0.01.
Figure 3
Figure 3. The expression of synapsin 1, VGAT and gephyrin positive synaptic puncta.
(A) The number of synapsin 1 positive puncta in the molecular layer of Cstb−/− cerebellum was significantly lower compared to controls at P14 (p = 0.0035) and P20 (p = 0.0447). P7 and P30 animals did not show significant difference. (B) Molecular layer of P14 and P20 Cstb−/− cerebellum shows less synapsin 1 positive puncta compared to control. (C) The number of VGAT positive puncta in the molecular layer of Cstb−/− cerebellum was significantly lower compared to controls at P14 (p = 0.0115). P7, P20 and P30 animals did not show significant difference. (D) Molecular layer of P14 Cstb−/− cerebellum shows less VGAT positive puncta compared to control. (E) The number of gephyrin positive puncta in the molecular layer of Cstb−/− cerebellum was significantly lower compared to controls at P20 (p = 0.0448) and P30 (p = 0.0131). P7 and P14 animals did not show significant difference. (F) Molecular layer of P20 and P30 Cstb−/− cerebellum shows less gephyrin positive puncta compared to control. The data are expressed as mean amount of positive puncta relative to control ± SE. *, p<0.05; **, p<0.01.
Figure 4
Figure 4. Autoradiography of GABAA receptors.
(A) Binding of [3H]muscimol was significantly reduced in P30 Cstb−/− cerebellum (p = 0.037). No change was seen at P7. (B) Binding of [3H]Ro15-4513 did not show significant changes at P7 or at P30. However, when diazepam (DZ) was added to reveal the diazepam-insensitive α6 subunit-dependent GABAA receptor subtype, decreased binding for [3H]Ro15-4513 (p = 0.012) was seen. The data are expressed as mean radioactivity levels (nCi/mg) ± SE. *, p<0.05. (C) Representative images of [3H]muscimol binding to P30 Cstb−/− and control brain. (D) Representative images of [3H]Ro15-4513 binding to P30 Cstb−/− and control brain without and (E) in presence of diazepam.

Similar articles

Cited by

References

    1. Kälviäinen R, Khyuppenen J, Koskenkorva P, Eriksson K, Vanninen R, et al. (2008) Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia 49: 549–556. - PubMed
    1. Lalioti MD, Scott HS, Buresi C, Rossier C, Bottani A, et al. (1997) Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386: 847–851. - PubMed
    1. Pennacchio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneva K, et al. (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271: 1731–1734. - PubMed
    1. Pennacchio LA, Bouley DM, Higgins KM, Scott MP, Noebels JL, et al. (1998) Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Genet 20: 251–258. - PubMed
    1. Lehtinen MK, Tegelberg S, Schipper H, Su H, Zukor H, et al. (2009) Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J Neurosci 29: 5910–5915. - PMC - PubMed

Publication types

MeSH terms